Hemab Therapeutics
DenmarkEntry
2021
Hold
5yr
Status
Active
Who owns Hemab Therapeutics?
Hemab Therapeutics is a Danish Biotech company, currently owned by Novo Holdings since 2021 and 2 other investors.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2020 · present
Sofinnova PartnersActive
2020 · present(6yr) · Sofinnova Crossover Fund I · 2018 · VC
HealthCapActive
2021 · present(5yr) · HealthCap VIII · 2021 · VC
Novo HoldingsActive
2021 · present(5yr) · Novo Holdings Seed Investments · 1999 · VC
More from HealthCap VIII
Other portfolio companies in the same fund.
Finland
Sweden
US
SwitzerlandMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Hemab Therapeutics?
Hemab Therapeutics is currently owned by Novo Holdings, HealthCap and 1 other, through HealthCap VIII, since 2021.
When did Novo Holdings and 2 others acquire Hemab Therapeutics?
Novo Holdings and 2 others acquired Hemab Therapeutics in 2021.
Who has owned Hemab Therapeutics over time?
Hemab Therapeutics has been through 3 private-equity ownership periods: Sofinnova Partners · via Sofinnova Crossover Fund I · since 2020; Novo Holdings · via Novo Holdings Seed Investments · since 2021; HealthCap · via HealthCap VIII · since 2021.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue